Skip to main content

Peer Review reports

From: Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam

Original Submission
10 Dec 2016 Submitted Original manuscript
5 Jan 2017 Reviewed Reviewer Report - Joshua S Davis
22 Mar 2017 Reviewed Reviewer Report - Andrea Kwa
12 Apr 2017 Author responded Author comments - Myra W. Popejoy
Resubmission - Version 2
12 Apr 2017 Submitted Manuscript version 2
19 Apr 2017 Author responded Author comments - Myra W. Popejoy
Resubmission - Version 3
19 Apr 2017 Submitted Manuscript version 3
Publishing
21 Apr 2017 Editorially accepted
2 May 2017 Article published 10.1186/s12879-017-2414-9

You can find further information about peer review here.

Back to article page